Global Cell Viability Assays Market: Overview
The global market for cell viability assays is estimated to grow as the funding on research activities is increasing during the forecast period. Cell viability assays is an assessment to determine the organ ability, tissues or cells so as to recover or improve viability. It can assist by assaying motility, mechanical activity, contraction, and others. All these activities are used during the viability assessment. Using viability dues, the counting of cells is performed which can offer viable cells percentage and proliferation rate. With the continuous focus on improving the cell-based therapeutics, the market for cell viability assays is expected to grow in the forecast period.
The study performed analyses the cell viability assays market through various segments such as market share, value, and production capacity in the upcoming years. The report also focusses on the key vendors to describe, analyze, and identify the competitive landscape such as SWOT analysis. Furthermore, the research report assists you to understand the factors impacting or restricting the cell viability assays market growth. It also analyses various company profiles by initiatives such as mergers and acquisitions, partnerships, new product development, and new launches. Primary and secondary research has been performed in order to study and analyze the cell viability assays market globally. The data used has been fetched from different secondary sources which includes annual reports, company website, recent press releases, investor presentations, and journals.
Global Cell Viability Assays Market: Key Drivers and Challenges
The growing prevalence and incidence of infectious and chronic disorders is predicted to augment the demand of cell viability assays market in the coming years. The rate of chronic diseases are projected to rise by 57% by the year 2020, says WHO. CDC further added that chronic disorders were the main cause of disability and death in the U.S in 2017. Furthermore, the rise of chronic disorders due to changing lifestyle and geriatric population leads to increase in spending and demand for healthcare. In terms of emerging markets, heart diseases and cancer is proving to be the primary cause of death owing to sedentary lifestyles, urbanization, growing obesity levels, frequent diet alterations, and widespread tobacco availability. As the chronic diseases are increasing in number, the market is witnessing a high demand with respect to assays so as to enable quick treatment and early detection. Therefore, the cell viability assays market is anticipated to offer immense opportunities for growth to the global leaders in the next few years.
One of the major limitation linked with the use of assays is the time taken to check the cell viability and it normally takes around 1-4 hours of incubation time. The absorbance process of detection used by several assays is not so easily affected as compared to luminescent and fluorescent methods while detecting cell number viability. Therefore, as the cell viability gets affected and which may damage cells at the time of performing experiment. All the above mentioned limitations are likely to impact the growth of global cell viability assays market in the coming years.
Global Cell Viability Assays Market: Regional Outlook
Geographically, the cell viability assays global market is divided into Europe, Latin America, MEA, and North America. North America followed by Asia pacific account for the majority of market share. This region is leading on the back of growing investment activities by government, superior quality clinical infrastructure, and rising incidence of several contaminated diseases. Other benefits supporting the growth of North America include growing R&D and healthcare expenditure, insurance coverage availability in terms of clinical procedures, and presence of super structured distribution channels.
Global Cell Viability Assays Market: Competitive Insight
Biotium (US), BioTek Instruments (US), Bio-Rad Laboratories (US), Merck (Germany), Thermo Fisher Scientific (US), PerkinElmer (US), GE Healthcare (US), and Promega Corporation are some of the key companies leading the cell viability global market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.